Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine

Yeon Ahn, Wenche Jy, W. J. Harrington, N. Shanbaky, L. F. Fernandez, D. H. Haynes

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Using chlorotetracycline (CTC) as a probe we studied calcium homeostasis of platelets in various disorders. Studied were healthy subjects and patients with disorders where platelets play an important role. These included thromboses, hypertension, diabetes mellitus, vasculitis, immune thrombocytopenia, thrombotic thrombocytopenic purpura, myelofibrosis, hemolytic anemias and uremia. Significant elevation of calcium levels were observed in all of these disorders except uremia. Nifedipine reduced or normalized the increased levels in most patients and its discontinuation resulted in a return of the abnormality. We propose that platelets in thromboses and related disorders are exposed to subcritical concentrations of activating factors, leading to enhanced calcium influx and elevated free cytoplasmic calcium followed by elevated resting dense tubular calcium. Nifedipine appears to protect platelets from these stimuli and coupled with their known action on vessel walls, calcium channel blockers show promise as antiatherogenic as well as antithrombotic agents.

Original languageEnglish
Pages (from-to)135-143
Number of pages9
JournalThrombosis Research
Volume45
Issue number2
DOIs
StatePublished - Jan 15 1987

Fingerprint

Nifedipine
Thrombosis
Blood Platelets
Calcium
Uremia
Thrombotic Thrombocytopenic Purpura
Chlortetracycline
Primary Myelofibrosis
Idiopathic Thrombocytopenic Purpura
Fibrinolytic Agents
Hemolytic Anemia
Calcium Channel Blockers
Vasculitis
Diabetes Mellitus
Healthy Volunteers
Homeostasis
Hypertension

Keywords

  • artherosclerosis
  • CTC probe
  • platelet
  • platelet calcium
  • thromboses

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine. / Ahn, Yeon; Jy, Wenche; Harrington, W. J.; Shanbaky, N.; Fernandez, L. F.; Haynes, D. H.

In: Thrombosis Research, Vol. 45, No. 2, 15.01.1987, p. 135-143.

Research output: Contribution to journalArticle

Ahn, Yeon ; Jy, Wenche ; Harrington, W. J. ; Shanbaky, N. ; Fernandez, L. F. ; Haynes, D. H. / Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine. In: Thrombosis Research. 1987 ; Vol. 45, No. 2. pp. 135-143.
@article{863868e9c0ea437b8ffafbd9e404d87b,
title = "Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine",
abstract = "Using chlorotetracycline (CTC) as a probe we studied calcium homeostasis of platelets in various disorders. Studied were healthy subjects and patients with disorders where platelets play an important role. These included thromboses, hypertension, diabetes mellitus, vasculitis, immune thrombocytopenia, thrombotic thrombocytopenic purpura, myelofibrosis, hemolytic anemias and uremia. Significant elevation of calcium levels were observed in all of these disorders except uremia. Nifedipine reduced or normalized the increased levels in most patients and its discontinuation resulted in a return of the abnormality. We propose that platelets in thromboses and related disorders are exposed to subcritical concentrations of activating factors, leading to enhanced calcium influx and elevated free cytoplasmic calcium followed by elevated resting dense tubular calcium. Nifedipine appears to protect platelets from these stimuli and coupled with their known action on vessel walls, calcium channel blockers show promise as antiatherogenic as well as antithrombotic agents.",
keywords = "artherosclerosis, CTC probe, platelet, platelet calcium, thromboses",
author = "Yeon Ahn and Wenche Jy and Harrington, {W. J.} and N. Shanbaky and Fernandez, {L. F.} and Haynes, {D. H.}",
year = "1987",
month = "1",
day = "15",
doi = "10.1016/0049-3848(87)90167-8",
language = "English",
volume = "45",
pages = "135--143",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine

AU - Ahn, Yeon

AU - Jy, Wenche

AU - Harrington, W. J.

AU - Shanbaky, N.

AU - Fernandez, L. F.

AU - Haynes, D. H.

PY - 1987/1/15

Y1 - 1987/1/15

N2 - Using chlorotetracycline (CTC) as a probe we studied calcium homeostasis of platelets in various disorders. Studied were healthy subjects and patients with disorders where platelets play an important role. These included thromboses, hypertension, diabetes mellitus, vasculitis, immune thrombocytopenia, thrombotic thrombocytopenic purpura, myelofibrosis, hemolytic anemias and uremia. Significant elevation of calcium levels were observed in all of these disorders except uremia. Nifedipine reduced or normalized the increased levels in most patients and its discontinuation resulted in a return of the abnormality. We propose that platelets in thromboses and related disorders are exposed to subcritical concentrations of activating factors, leading to enhanced calcium influx and elevated free cytoplasmic calcium followed by elevated resting dense tubular calcium. Nifedipine appears to protect platelets from these stimuli and coupled with their known action on vessel walls, calcium channel blockers show promise as antiatherogenic as well as antithrombotic agents.

AB - Using chlorotetracycline (CTC) as a probe we studied calcium homeostasis of platelets in various disorders. Studied were healthy subjects and patients with disorders where platelets play an important role. These included thromboses, hypertension, diabetes mellitus, vasculitis, immune thrombocytopenia, thrombotic thrombocytopenic purpura, myelofibrosis, hemolytic anemias and uremia. Significant elevation of calcium levels were observed in all of these disorders except uremia. Nifedipine reduced or normalized the increased levels in most patients and its discontinuation resulted in a return of the abnormality. We propose that platelets in thromboses and related disorders are exposed to subcritical concentrations of activating factors, leading to enhanced calcium influx and elevated free cytoplasmic calcium followed by elevated resting dense tubular calcium. Nifedipine appears to protect platelets from these stimuli and coupled with their known action on vessel walls, calcium channel blockers show promise as antiatherogenic as well as antithrombotic agents.

KW - artherosclerosis

KW - CTC probe

KW - platelet

KW - platelet calcium

KW - thromboses

UR - http://www.scopus.com/inward/record.url?scp=0023100122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023100122&partnerID=8YFLogxK

U2 - 10.1016/0049-3848(87)90167-8

DO - 10.1016/0049-3848(87)90167-8

M3 - Article

C2 - 3563979

AN - SCOPUS:0023100122

VL - 45

SP - 135

EP - 143

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 2

ER -